Related Experiment Video

Updated: Dec 17, 2025

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
08:24

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach

Published on: May 2, 2018

20.3K

Systemic inflammatory response and thrombosis due to alterations in the gut microbiota in COVID-19

Klaus Mönkemüller1, Lucia C Fry2, Steffen Rickes3

  • 1Gastroenterology, Helios Kliniken, Germany.

Revista Espanola De Enfermedades Digestivas
|June 25, 2020
PubMed

Insights

This letter acknowledges comments regarding COVID-19 and its impact on the small bowel. It emphasizes the significance of thromboembolic complications, such as bowel ischemia, in patients with Coronavirus disease 2019 (COVID-19).

Area of Science:

  • Gastroenterology
  • Infectious Diseases
  • Vascular Medicine

Background:

  • The publication "COVID-19, Coronavirus, SARS-CoV-2 and the small bowel" is discussed.
  • Comments from Cienfuegos et al. regarding thromboembolic complications in COVID-19 patients are addressed.

Discussion:

  • Thromboembolic complications, specifically bowel ischemia, are a critical concern in Coronavirus disease 2019 (COVID-19) patients.
  • The importance of recognizing bowel ischemia as a complication of SARS-CoV-2 infection is highlighted.
  • Autopsy studies corroborate the occurrence of these vascular events in COVID-19.

Key Insights:

  • Bowel ischemia is a significant gastrointestinal complication associated with COVID-19.
  • Early recognition and management of thromboembolic events are crucial for COVID-19 patient outcomes.
  • The link between SARS-CoV-2 infection and vascular complications warrants further investigation.

Outlook:

  • Further research into the mechanisms underlying COVID-19-associated thromboembolism is needed.
  • Clinical vigilance for gastrointestinal complications in COVID-19 patients should be maintained.
  • Collaborative efforts are essential to understand and manage the multifaceted effects of SARS-CoV-2.

More Related Videos

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

3.2K
Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

30.9K

Related Concept Videos

Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
815
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
680
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.1K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
744
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
800
Other Disorders of Digestive System01:30

Other Disorders of Digestive System

The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
1.3K